• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Where is the Ethical Debate around Phenotypic Screening of Prenatal Tissue Using Stem Cell-Derived Tissue Constructs?

作者信息

Harris Alexander R, Walker Mary Jean, Gilbert Frederic, McGivern Patrick

机构信息

Department of Biomedical Engineering, University of Melbourne, Melbourne, VIC, 3010, Australia.

Department of Politics, Media, and Philosophy, La Trobe University, Bundoora, VIC, 3086, Australia.

出版信息

Stem Cell Rev Rep. 2025 Jan;21(1):280-282. doi: 10.1007/s12015-024-10795-3. Epub 2024 Oct 2.

DOI:10.1007/s12015-024-10795-3
PMID:39356391
Abstract
摘要

相似文献

1
Where is the Ethical Debate around Phenotypic Screening of Prenatal Tissue Using Stem Cell-Derived Tissue Constructs?围绕使用干细胞衍生组织构建体对产前组织进行表型筛查的伦理辩论在哪里？
Stem Cell Rev Rep. 2025 Jan;21(1):280-282. doi: 10.1007/s12015-024-10795-3. Epub 2024 Oct 2.
2
Investigating the feasibility and ethical implications of phenotypic screening using stem cell-derived tissue models to detect and manage disease.利用干细胞衍生组织模型进行表型筛选以检测和管理疾病的可行性和伦理影响研究。
Stem Cell Reports. 2022 May 10;17(5):1023-1032. doi: 10.1016/j.stemcr.2022.04.002. Epub 2022 Apr 28.
3
Defining Biomarkers in Stem Cell-Derived Tissue Constructs for Drug and Disease Screening.定义用于药物和疾病筛选的干细胞衍生组织构建体中的生物标志物。
Adv Healthc Mater. 2024 Oct;13(26):e2401433. doi: 10.1002/adhm.202401433. Epub 2024 May 14.
4
Qualifying choice: ethical reflection on the scope of prenatal screening.合格的选择：对产前筛查范围的伦理反思
Med Health Care Philos. 2017 Jun;20(2):195-205. doi: 10.1007/s11019-016-9725-2.
5
Organoid Ethical Typology: varieties of three-dimensional stem cell constructs and the many issues they raise in bioethics.类器官伦理类型学：三维干细胞构建体的种类及其在生物伦理学中引发的诸多问题。
Biol Cell. 2025 Jan;117(1):e2400093. doi: 10.1111/boc.202400093.
6
A comparison of the functionality and in vivo phenotypic stability of cartilaginous tissues engineered from different stem cell sources.不同干细胞来源构建的软骨组织的功能和体内表型稳定性比较。
Tissue Eng Part A. 2012 Jun;18(11-12):1161-70. doi: 10.1089/ten.TEA.2011.0544. Epub 2012 Apr 27.
7
Should prenatal screening be seen as 'selective reproduction'? Four reasons to reframe the ethical debate.产前筛查是否应被视为“选择性繁殖”？重新构建伦理辩论的四个理由。
J Perinat Med. 2021 Jul 1;49(8):953-958. doi: 10.1515/jpm-2021-0239. Print 2021 Oct 26.
8
How to depolarise the ethical debate over human embryonic stem cell research (and other ethical debates too!).如何消除人类胚胎干细胞研究（以及其他伦理辩论）的伦理辩论中的极化现象！
J Med Ethics. 2012 Aug;38(8):496-500. doi: 10.1136/medethics-2011-100099. Epub 2012 Feb 28.
9
Ethical implications and practical considerations of ethnically targeted screening for genetic disorders: the case of hemoglobinopathy screening.种族靶向性遗传疾病筛查的伦理意义和实际考虑：以血红蛋白病筛查为例。
Ethn Health. 2011 Aug-Oct;16(4-5):377-88. doi: 10.1080/13557858.2010.541902.
10
Tissue Engineering Techniques for Induced Pluripotent Stem Cell Derived Three-Dimensional Cardiac Constructs.诱导多能干细胞衍生的三维心脏构建的组织工程技术。
Tissue Eng Part B Rev. 2022 Aug;28(4):891-911. doi: 10.1089/ten.TEB.2021.0088. Epub 2021 Nov 23.

本文引用的文献

1
Investigating the feasibility and ethical implications of phenotypic screening using stem cell-derived tissue models to detect and manage disease.利用干细胞衍生组织模型进行表型筛选以检测和管理疾病的可行性和伦理影响研究。
Stem Cell Reports. 2022 May 10;17(5):1023-1032. doi: 10.1016/j.stemcr.2022.04.002. Epub 2022 Apr 28.
2
Induced Pluripotent Stem Cell-Based Systems for Personalising Epilepsy Treatment: Research Ethics Challenges and New Insights for the Ethics of Personalised Medicine.基于诱导多能干细胞的个性化癫痫治疗系统：研究伦理挑战与个性化医学伦理的新见解
AJOB Neurosci. 2022 Apr-Jun;13(2):120-131. doi: 10.1080/21507740.2021.1949404. Epub 2021 Jul 29.
3
Challenges in the Regulation of Autologous Stem Cell Interventions in the United States.
美国自体干细胞干预监管中的挑战。
Perspect Biol Med. 2018;61(1):25-41. doi: 10.1353/pbm.2018.0025.
4
The US Direct-to-Consumer Marketplace for Autologous Stem Cell Interventions.美国自体干细胞干预的直接面向消费者市场。
Perspect Biol Med. 2018;61(1):7-24. doi: 10.1353/pbm.2018.0024.
5
Public attitudes towards genetic testing revisited: comparing opinions between 2002 and 2010.重新审视公众对基因检测的态度：比较 2002 年和 2010 年的意见。
Eur J Hum Genet. 2013 Aug;21(8):793-9. doi: 10.1038/ejhg.2012.271. Epub 2012 Dec 19.
6
Population genetic screening programmes: principles, techniques, practices, and policies.群体遗传筛查计划：原理、技术、实践与政策
Eur J Hum Genet. 2003 Dec;11 Suppl 2:S49-87. doi: 10.1038/sj.ejhg.5201113.